Stellenmarkt Ein Angebot aus dem Karriere-Netzwerk von Jobbörse der ZEIT - Alle aktuellen Jobs im ZEIT Stellenmarkt

Bitte beachten Sie: Diese Stellenanzeige ist nicht mehr aktiv
Ähnliche aktuelle Stellenangebote
Geschäftsführer (m/w)
Professur (W3) für Translationale Pneumologie
Universitätsklinikum Heidelberg
Mehr Jobs anzeigen
Passende Stellenangebote per Email

Erfahren Sie es als Erster, wenn
neue Stellenangebote online sind
‐ mit dem ZEIT Stellenmarkt
Job-Newsletter Service.

Passende JOBS per Mail
BIH Chair for Cell and Gene Therapy and Coordinator of the Advanced Therapies Program

Berliner Institut für Gesundheitsforschung (BIG) - Berlin Institute of Health (BIH). Berlin, 23.02.2017

The Berlin Institute of Health (BIH) is a new health research institution forming a translational research commons for over 4,000 clinicians and scientists of Charité - Universitätsmedizin Berlin, one of Europe’s largest academic health systems, and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), a global leader in molecular biology and genetics research. With its strategic priorities on personalized medicine and advanced therapies for debilitating progressive diseases, the BIH is now conducting global searches for five inaugural Chairs who will each establish innovative, interactive research centers and programs in digital health, clinical-translational sciences, genomic medicine, disease modelling, and cell and gene therapies, respectively.

BIH Chair for Cell and Gene Therapy and Coordinator of the Advanced Therapies Program

The Candidate
The BIH invites applications for the position of BIH Chair for Cell and Gene Therapy and Coordinator of the Advanced Therapies Program. The Chair will possess appropriate stature as an international leader with outstanding track record of high-impact research and demonstrated expertise in the development of cell-based therapies, specifically stem cell therapy or immune cell therapy, as well as gene therapy, or genome editing technology and its (pre-)clinical exploitation. Knowledge of therapeutics manufacturing processes for (pre-)clinical development is desirable.

The Opportunity
The Chair will provide vision and leadership to establish world-class basic and / or translational research and coordinate the Advanced Therapies Program. The Chair is expected to foster collaborations among investigators, and to promote outreach with clinician investigators and industry. The candidate should articulate a compelling vision for the future of cell and gene therapies in the context of an interdisciplinary BIH Advanced Therapies Program. The Chair will work with leading researchers and clinicians to foster translational collaboration of the BIH research commons and interact with complementary structures of Charité and MDC. The position is affiliated with the Charité.

The candidates must qualify for appointment as full professor (W3-level professor) of the Charité - Universitäts­medizin Berlin in fulfillment of the professional conditions of appointment according to § 100 of the Berlin Higher Education Act. The successful candidates will be dynamic individuals with excellent interpersonal and leadership skills, an excellent third-party funding record, administrative expertise, and proven commitment to education and mentorship of students, fellows and faculty. Experience with industry partnerships and regulatory environments is a plus.

The BIH actively promotes equal opportunity and welcomes applications from candidates regardless of their cultural and social background, age, religion, belief, disability or sexual orientation. Applications of women are explicitly encouraged. Applicants with a disability are given preferred consideration if equally qualified.

For further information about BIH and enquiries about the position please visit or contact Prof. Dr. Erwin Böttinger (

Interested candidates should send their applications including a cover letter, a curriculum vitae and a brief statement of the envisioned research program (3-5 pages) in a single PDF file (maximum file size 8 MB) to by April 7, 2017. In addition, three independent letters of recommendation should be sent directly to by the same deadline.

Bewerbungsschluss: 07.04.2017